GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,283,000 | -14.1% | 36,631 | 0.0% | 0.68% | -20.2% |
| Q1 2021 | $1,493,000 | -18.2% | 36,631 | -13.2% | 0.85% | -27.4% |
| Q4 2020 | $1,826,000 | -21.6% | 42,196 | 0.0% | 1.17% | -18.6% |
| Q3 2020 | $2,328,000 | -7.3% | 42,196 | +6.1% | 1.44% | -17.9% |
| Q2 2020 | $2,510,000 | +4.8% | 39,762 | -15.2% | 1.75% | -21.8% |
| Q1 2020 | $2,395,000 | -35.7% | 46,873 | 0.0% | 2.24% | -10.2% |
| Q4 2019 | $3,726,000 | +193.4% | 46,873 | +79.1% | 2.50% | +175.0% |
| Q3 2019 | $1,270,000 | – | 26,176 | – | 0.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
| Grace Capital | 131,549 | $5,697,000 | 3.60% |
| Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
| Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
| Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
| Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
| ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
| Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
| Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
| Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |